TAKE ACTION: Tell the USDA to do its job: protect consumers, not the biotech industry!

Now, under the Trump administration’s “ free-for-all ” approach to regulation, the USDA wants to let companies like Monsanto-Bayer, DowDupont and Syngenta (now owned by ChemChina) “regulate” their own genetically engineered products.

Two years ago, the U.S. Department of Agriculture (USDA), with help from then-President Obama, effectively stripped consumers of their right to know if their food contains GMO ingredients.

From the department of “you can’t make this stuff up,” the USDA calls its new proposed rule for reviewing and approving GMOs “Sustainable, Ecological, Consistent, Uniform, Responsible, Efficient,” or “SECURE” for short.

If this new rule is allowed to take effect, biotech companies will for sure be more secure—secure in the fact that they will be allowed to unleash any genetically engineered organism into the environment or into the food system—with no oversight, no independent testing and no accountability.

The USDA’s proposed rule follows Trump’s executive order, issued in June, calling for “modernizing the regulatory framework for agricultural biotechnology products.” Which is just shorthand for protecting corporate profits at the expense of human health and the environment.

If passed, “SECURE” will also be a disaster for organic farmers, whose organic certification—and livelihoods—will be threatened even further by contamination of their non-GMO, organic crops when GMO seeds “drift” into their fields.

Under USDA’s proposed “no-regulation rule,” almost every GMO would be exempt from regulation. And biotech companies would be the ones to decide whether or not their frankenfoods are “safe.”

As Dr. Allison A. Snow, professor of evolution, ecology and organismal biology at Ohio State University, wrote to the New York Times in 2015:

Asserting that biotech is safe is like saying that electricity is safe. Genetic engineering can be used safely or stupidly. Scientists, corporations and government agencies try to avoid the latter, and regulators need strong scientific data to evaluate risks.

Snow had this to say to a National Geographic reporter:

"Every transgenic organism brings with it a different set of potential risks and benefits," says Snow. "Each needs to be evaluated on a case-by-case basis. But right now only one percent of USDA biotech research money goes to risk assessment."

In other words, we need more—not less—regulation of GMOs, especially in the rapidly changing era of new “gene-editing” technologies such as CRISPR and RNA interference (RNAi).

As Snow said, even before the USDA’s new proposed plan to hand over the regulation of GMOs to biotech corporations:

"We've let the cat out of the bag before we have real data, and there's no calling it back."

Given the coordinated effort and relentless push by the biotech industry and the USDA to deregulate, it may also be too late to “call back” this latest proposed rule. But try we must.